Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 21 peer-reviewed journal articles Updated
Neurology · Kernicterus Spectrum Disorder

Building a Care Plan: Managing KSD Symptoms

At a Glance

Kernicterus Spectrum Disorder (KSD) is highly manageable through a multidisciplinary care plan. Treatment focuses on physical therapy and medications for dystonia, cochlear implants for hearing loss, and specialized preventive care for dental and feeding challenges.

While there is currently no cure for the brain injury caused by severe jaundice, Kernicterus Spectrum Disorder (KSD) is highly manageable. The goal of care is to address the “tetrad” of symptoms through a coordinated, multidisciplinary approach involving neurologists, therapists, audiologists, and dentists [1][2]. This aggressive management focuses on maximizing your child’s functional independence and comfort.

Managing Motor Challenges and Dystonia

The movement disorders in KSD—primarily dystonia (muscle stiffness/twisting) and choreoathetosis (involuntary movements)—are managed through a “ladder” of options, starting with foundational therapies and moving toward medication or surgery only as needed.

  • Therapeutic Foundation (PT/OT): The first and most critical step in managing motor symptoms is continuous Physical Therapy (PT) and Occupational Therapy (OT). Intensive neuromotor therapies help train the brain to bypass damaged pathways (neuroplasticity) and prevent joint stiffness (contractures) [2].
  • Pharmacological Options: If therapies aren’t enough to manage severe dystonia, medications may be prescribed. Crucially, these medications have significant side effects. Because children with KSD often struggle with communication, parents must monitor for side effects like severe sedation, cognitive blunting (feeling “foggy”), or behavioral changes.
    • Trihexyphenidyl: Often used as a first-line medication, it can improve dystonia but requires careful dosing [3][4].
    • Baclofen and Benzodiazepines (like Clonazepam): Used to relax muscles and reduce “movement storms.” They carry risks of significant sedation and withdrawal if stopped abruptly [5][6].
  • Surgical Interventions (For Severe/Older Cases):
    • Intrathecal Baclofen (ITB) Pump: For children with severe dystonia who cannot tolerate oral medications, a small pump can be surgically placed to deliver baclofen directly into the spinal fluid [7][8].
    • Deep Brain Stimulation (DBS): Electrodes are placed in the globus pallidus (GPi) to regulate abnormal brain signals. This is typically reserved for older children with severe, treatment-resistant movement challenges [9][10].

Addressing Hearing and ANSD

Because KSD causes Auditory Neuropathy Spectrum Disorder (ANSD), traditional hearing aids often provide limited benefit. Hearing aids amplify sound, but they cannot fix the “scrambled” signal caused by nerve damage [11][12].

  • Cochlear Implants (CI): These are now considered the standard of care for children with KSD and significant hearing challenges [11]. Unlike hearing aids, a cochlear implant bypasses the damaged parts of the auditory system to provide a clearer signal to the brain. Children with ANSD who receive implants often achieve language development similar to children with other types of hearing loss [13][14].

Dental Care for Enamel Hypoplasia

The enamel hypoplasia (thin or pitted enamel) caused by bilirubin makes teeth much more vulnerable to cavities (caries) [15][16].

  • Prevention: Management includes aggressive preventive care, such as high-fluoride “remineralizing” treatments and frequent cleanings [17][18].
  • Restoration: Dentists may use composite resin restorations or resin infiltration to “fill in” the pitted areas, protecting the tooth structure and masking any yellowish or greenish discoloration [19][20].

Vision and Feeding Support

Children with KSD often face challenges with upward gaze palsy and dysphagia (swallowing difficulties).

  • Feeding Safety: Because motor control is affected, children may “silently aspirate” (food or liquid entering the lungs without coughing). A videofluoroscopic swallow study (VFSS) is often recommended to ensure feeding is safe [21].
  • Vision Adaptations: Working with a pediatric ophthalmologist or vision therapist can help families find ways to position toys, screens, and schoolwork to accommodate the child’s vertical gaze limitations.

Common questions in this guide

How is dystonia treated in children with KSD?
Dystonia is primarily managed through intensive physical and occupational therapy to train the brain and prevent joint stiffness. If therapies are not enough, medications or surgical options like an intrathecal baclofen pump or deep brain stimulation may be considered.
Will hearing aids help my child's hearing loss from KSD?
Because KSD causes nerve damage that scrambles sound signals, traditional hearing aids often provide limited benefit. Cochlear implants are considered the standard of care, as they bypass the damaged auditory system to provide a clearer signal to the brain.
Why does KSD cause dental issues and frequent cavities?
Bilirubin damage causes enamel hypoplasia, leaving teeth thin or pitted and highly vulnerable to cavities. Aggressive preventive care, including high-fluoride remineralizing treatments and frequent cleanings, is essential to protect their teeth.
How can I ensure my child is swallowing safely during meals?
Children with KSD may experience silent aspiration, where food or liquid enters the lungs without causing them to cough. Doctors often recommend a videofluoroscopic swallow study (VFSS) to evaluate swallowing safety and ensure feedings are secure.
What side effects should I watch for if my child takes medication for dystonia?
Medications like trihexyphenidyl or baclofen can help relax muscles, but they carry risks of significant sedation, cognitive blunting, and behavioral changes. Parents must closely monitor their child for these side effects, as children with KSD may struggle to communicate how they feel.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Based on my child's specific movement patterns, should we prioritize Physical Therapy or explore pharmacological options like trihexyphenidyl?
  2. 2.If we start baclofen or a benzodiazepine, what specific side effects should I be monitoring for daily?
  3. 3.Can we schedule a specialized swallow study (like a VFSS) to ensure my child isn't experiencing silent aspiration during feedings?
  4. 4.What is our timeline for evaluating the effectiveness of hearing aids versus moving toward cochlear implantation for their ANSD?
  5. 5.Are there specific 'remineralizing' toothpastes or sealants you recommend for protecting my child's teeth with enamel hypoplasia?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (21)
  1. 1

    A questionnaire survey on the efficacy of various treatments for dyskinetic cerebral palsy due to preterm bilirubin encephalopathy.

    Kitai Y, Hirai S, Okuyama N, et al.

    Brain & development 2020; (42(4)):322-328 doi:10.1016/j.braindev.2020.01.006.

    PMID: 32063420
  2. 2

    Case study on the use of intensive pediatric neurorehabilitation in the treatment of kernicterus.

    Mann J, Wallace DA, DeLuca S

    Journal of clinical movement disorders 2020; (7()):1 doi:10.1186/s40734-020-0084-z.

    PMID: 32042435
  3. 3

    Trihexyphenidyl in young children with dystonic cerebral palsy: A single arm study.

    Rajkumar L, Ventatakrishnan A, Sairam S, et al.

    Journal of pediatric rehabilitation medicine 2023; (16(1)):115-124 doi:10.3233/PRM-210087.

    PMID: 36373299
  4. 4

    Gabapentin as Add-on Therapy to Trihexyphenidyl in Children with Dyskinetic Cerebral Palsy: A Randomized, Controlled Trial.

    Kumar S, Shankar Kaushik J, Verma S, Dabla S

    Indian journal of pediatrics 2023; (90(9)):873-879 doi:10.1007/s12098-022-04265-2.

    PMID: 35867274
  5. 5

    National Prescribing Practices for Pediatric Dystonia Among Providers in the United States.

    Davis SPW, Kane N, Botteron HE, Gelineau-Morel R

    Clinical and translational science 2025; (18(2)):e70171 doi:10.1111/cts.70171.

    PMID: 39972534
  6. 6

    Clinical Presentations and Treatment of Baclofen Toxicity and Withdrawal: A Systematic Review.

    Iqbal M, Modi P, Sehgal K, et al.

    CNS drugs 2026; (40(3)):419-449 doi:10.1007/s40263-025-01254-9.

    PMID: 41555041
  7. 7

    Intrathecal baclofen pumps in the management of hypertonia in childhood: a UK and Ireland wide survey.

    Lodh R, Amin S, Ammar A, et al.

    Archives of disease in childhood 2021; (106(12)):1202-1206 doi:10.1136/archdischild-2020-321487.

    PMID: 33853760
  8. 8

    Intrathecal Baclofen Pump Versus Globus Pallidus Interna Deep Brain Stimulation in Adult Patients with Severe Cerebral Palsy.

    Kim JH, Jung NY, Chang WS, et al.

    World neurosurgery 2019; (126()):e550-e556 doi:10.1016/j.wneu.2019.02.092.

    PMID: 30831291
  9. 9

    Pallidus Stimulation for Chorea-Acanthocytosis: A Systematic Review and Meta-Analysis of Individual Data.

    He W, Li C, Dong H, et al.

    Journal of movement disorders 2022; (15(3)):197-205 doi:10.14802/jmd.22003.

    PMID: 35880382
  10. 10

    Pallidal Deep Brain Stimulation Reduces Sensorimotor Cortex Activation in Focal/Segmental Dystonia.

    Greuel A, Pauls KAM, Koy A, et al.

    Movement disorders : official journal of the Movement Disorder Society 2020; (35(4)):629-639 doi:10.1002/mds.27970.

    PMID: 31922299
  11. 11

    Hearing loss and cochlear implantation in Chudley McCullough syndrome: A case series.

    Boerboom RA, Engels S, Ebbens FA, et al.

    Cochlear implants international 2026; (27(1)):73-80 doi:10.1080/14670100.2025.2607227.

    PMID: 41503747
  12. 12

    Prevalence, risk factors, and audiological characteristics of auditory neuropathy.

    Almishaal AA, Saleh S, Alferaih H, Alhelo O

    International journal of audiology 2022; (61(12)):1018-1026 doi:10.1080/14992027.2021.2014074.

    PMID: 34928752
  13. 13

    Comparative Outcomes of Cochlear Implantation in Children with Auditory Neuropathy Spectrum Disorder and Sensorineural Hearing Loss: A Systematic Review and Meta-Analysis.

    Tawakkul Q, Alsanosi S, Alahmadi A, et al.

    Audiology & neuro-otology 2025; (30(6)):545-555 doi:10.1159/000546962.

    PMID: 40623386
  14. 14

    Language and Memory Skills in Pediatric Cochlear Implant Users With Auditory Neuropathy Spectrum Disorder.

    İkiz Bozsoy M, Parlak Kocabay A, Yücel E

    Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology 2026; (47(2)):e216-e222 doi:10.1097/MAO.0000000000004725.

    PMID: 41250166
  15. 15

    Risk Factors for Early Childhood Caries: A Systematic Review and Meta-Analysis of Case Control and Cohort Studies.

    Kirthiga M, Murugan M, Saikia A, Kirubakaran R

    Pediatric dentistry 2019; (41(2)):95-112.

    PMID: 30992106
  16. 16

    Prevalence of enamel defects and association with dental caries in preschool children.

    Massignan C, Ximenes M, da Silva Pereira C, et al.

    European archives of paediatric dentistry : official journal of the European Academy of Paediatric Dentistry 2016; (17(6)):461-466 doi:10.1007/s40368-016-0254-8.

    PMID: 27848202
  17. 17

    Oral Manifestations in Different Subtypes of Hereditary Epidermolysis Bullosa: A Retrospective Case Series From an Asian Cohort.

    Li ML, Huang YL, Lin S, et al.

    Oral diseases 2025; doi:10.1111/odi.70114.

    PMID: 41078244
  18. 18

    Caries experience of children with cardiac conditions attending the Royal Children's Hospital of Melbourne.

    Oliver KJ, Cheung M, Hallett K, Manton DJ

    Australian dental journal 2018; (63(4)):429-440 doi:10.1111/adj.12647.

    PMID: 30125372
  19. 19

    Enamel hypoplasia: challenges of esthetic restorative treatment.

    Ruschel VC, Araújo É, Bernardon JK, Lopes GC

    General dentistry 2016; (64(5)):75-8.

    PMID: 27599287
  20. 20

    Effectiveness and Color Stability of Resin Infiltration on Demineralized and Hypomineralized (MIH) Enamel in Children: Six-month Results of a Prospective Trial.

    Ozgur B, Unverdi GE, Ertan AA, Cehreli ZC

    Operative dentistry 2023; (48(3)):258-267 doi:10.2341/22-041-C.

    PMID: 36917623
  21. 21

    [Screening of pediatric oropharyngeal dysphagia in cerebral palsy].

    Outón Arteaga A, Díaz Borrego P

    Rehabilitacion 2025; (59(4)):100951 doi:10.1016/j.rh.2025.100951.

    PMID: 41240437

This page provides educational information on managing Kernicterus Spectrum Disorder (KSD) symptoms. Always consult your child's neurologist, audiologist, and pediatrician before making changes to their medical care plan.

Get notified when new evidence is published on Chronic bilirubin encephalopathy.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.